175 related articles for article (PubMed ID: 35789772)
1. Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients.
Nygren D; Mölstad U; Thulesius H; Hillman M; Broman LM; Tanash H; Landin-Olsson M; Rasmussen M; Thunander M
Int J Gen Med; 2022; 15():5843-5848. PubMed ID: 35789772
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil.
Russo R; Zillmer LR; Nascimento OA; Manzano B; Ivanaga IT; Fritscher L; Lundgren F; Miravitlles M; Gondim HD; Santos G; Alves MA; Oliveira MV; Souza AA; Sales MP; Jardim JR
J Bras Pneumol; 2016; 42(5):311-316. PubMed ID: 27812629
[TBL] [Abstract][Full Text] [Related]
3. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.
Veith M; Tüffers J; Peychev E; Klemmer A; Kotke V; Janciauskiene S; Wilhelm S; Bals R; Koczulla AR; Vogelmeier CF; Greulich T
Int J Chron Obstruct Pulmon Dis; 2020; 15():2827-2836. PubMed ID: 33192056
[TBL] [Abstract][Full Text] [Related]
4. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency.
Hamesch K; Strnad P
Chronic Obstr Pulm Dis; 2020 Jul; 7(3):260-271. PubMed ID: 32697896
[TBL] [Abstract][Full Text] [Related]
5. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study.
Rodríguez Hermosa JL; Vargas Centanaro G; González Castro ME; Miravitlles M; Lázaro-Asegurado L; Jiménez-Rodríguez BM; Rodríguez RA; Moreno Méndez R; Torres-Duran M; Hernández-Pérez JM; Humanes-Navarro AM; Calle Rubio M
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831051
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.
Kueppers F
Respir Med Case Rep; 2021; 32():101345. PubMed ID: 33552892
[TBL] [Abstract][Full Text] [Related]
7. [Alpha-2 Macroglobulin Serum Level in Patients with Alpha-1 Antitrypsin Deficiency].
Kotke V; Wiedmann S; Nell C; Vogelmeier C; Bals R; Greulich T; Klemmer A
Pneumologie; 2017 Sep; 71(9):580-586. PubMed ID: 28449136
[No Abstract] [Full Text] [Related]
8. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
Franciosi AN; Carroll TP; McElvaney NG
Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Alpha-1 Antitrypsin Deficiency, Self-Reported Behavior Change, and Health Care Engagement Among Direct-to-Consumer Recipients of a Personalized Genetic Risk Report.
Ashenhurst JR; Nhan H; Shelton JF; Wu S; Tung JY; Elson SL; Stoller JK;
Chest; 2022 Feb; 161(2):373-381. PubMed ID: 34656525
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
11. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
[TBL] [Abstract][Full Text] [Related]
12. Comparison of COVID-19 Outcomes With Alpha-1 Antitrypsin Deficiency Prevalence in Europe: A Cross-Sectional Study.
Sezgin Y; Becel S; Kaplan AK
Cureus; 2023 Jan; 15(1):e34293. PubMed ID: 36860224
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
Fromme M; Schneider CV; Pereira V; Hamesch K; Pons M; Reichert MC; Benini F; Ellis P; H Thorhauge K; Mandorfer M; Burbaum B; Woditsch V; Chorostowska-Wynimko J; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Abreu N; Jasmins L; Gaspar R; Liberal R; Macedo G; Mahadeva R; Gomes C; Schneider KM; Trauner M; Krag A; Gooptu B; Thorburn D; Marshall A; Hurst JR; Lomas DA; Lammert F; Gaisa NT; Clark V; Griffiths W; Trautwein C; Turner AM; McElvaney NG; Strnad P
Gut; 2022 Feb; 71(2):415-423. PubMed ID: 33632708
[TBL] [Abstract][Full Text] [Related]
14. Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency.
McElvaney OJ; Cleary B; Fraughen DD; Kelly G; McElvaney OF; Murphy MP; Branagan P; Gunaratnam C; Carroll TP; Goss CH; McElvaney NG
Chronic Obstr Pulm Dis; 2024 Jan; 11(1):3-12. PubMed ID: 37676644
[TBL] [Abstract][Full Text] [Related]
15. A Novel Detection Method to Identify Individuals with Alpha-1 Antitrypsin Deficiency: Linking Prescription of COPD Medications with the Patient-Facing Electronic Medical Record.
Lam SW; Strange C; Brantly ML; Stoller JK
Chronic Obstr Pulm Dis; 2022 Jan; 9(1):26-33. PubMed ID: 34784453
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
17. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
18. Clinical considerations in individuals with α
McElvaney GN; Sandhaus RA; Miravitlles M; Turino GM; Seersholm N; Wencker M; Stockley RA
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32165400
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
20. Liver disease progression in patients with alpha-1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease.
Wu T; Hagiwara M; Gnass E; Barman H; Sasson D; Treem W; Ren K; Marins EG; Karki C; Malhi H
Aliment Pharmacol Ther; 2023 Nov; 58(10):1075-1085. PubMed ID: 37718576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
